Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Legname

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Frontiers in Neuroscience|February 7, 2018
Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative DiseasesSilvia Vanni, Marco Zattoni, Fabio Moda, et al.
Elife|April 14, 2021
PMCA-generated prions from the olfactory mucosa of patients with Fatal Familial Insomnia cause prion disease in miceEdoardo Bistaffa, Alba Marín-Moreno, Juan Carlos Espinosa, et al.
Neuron|March 29, 2025
Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signaturesCarlo Scialò, Weijia Zhong, Somanath Jagannath, et al.
Chemmedchem|June 12, 2010
Discovery of a class of diketopiperazines as antiprion compoundsMaria Laura Bolognesi, Hoang Ngoc Ai Tran, Matteo Staderini, et al.
Neuropathology and Applied Neurobiology|July 27, 2021
Expression pattern of perilipins in human brain during aging and in Alzheimer's diseaseMaria Conte, Valentina Medici, Davide Malagoli, et al.
ACS Chemical Neuroscience|November 29, 2022
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a <i>Drosophila</i> Model of Alzheimer's DiseaseAnnachiara Gandini, Ana Elisa Gonçalves, Silvia Strocchi, et al.
Acta Neuropathologica|January 6, 2018
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterationsIlaria Prada, Martina Gabrielli, Elena Turola, et al.
Journal of Medicinal Chemistry|June 30, 2022
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion ClearanceArianna Colini Baldeschi, Marco Zattoni, Silvia Vanni, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion DiseasesMatteo Staderini, Suzana Aulić, Manuela Bartolini, et al.
Molecular Neurobiology|April 13, 2022
Serpin Signatures in Prion and Alzheimer's DiseasesMarco Zattoni, Marika Mearelli, Silvia Vanni, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Frontiers in Neuroscience|February 7, 2018
Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative DiseasesSilvia Vanni, Marco Zattoni, Fabio Moda, et al.
Elife|April 14, 2021
PMCA-generated prions from the olfactory mucosa of patients with Fatal Familial Insomnia cause prion disease in miceEdoardo Bistaffa, Alba Marín-Moreno, Juan Carlos Espinosa, et al.
Neuron|March 29, 2025
Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signaturesCarlo Scialò, Weijia Zhong, Somanath Jagannath, et al.
Chemmedchem|June 12, 2010
Discovery of a class of diketopiperazines as antiprion compoundsMaria Laura Bolognesi, Hoang Ngoc Ai Tran, Matteo Staderini, et al.
Neuropathology and Applied Neurobiology|July 27, 2021
Expression pattern of perilipins in human brain during aging and in Alzheimer's diseaseMaria Conte, Valentina Medici, Davide Malagoli, et al.
ACS Chemical Neuroscience|November 29, 2022
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a <i>Drosophila</i> Model of Alzheimer's DiseaseAnnachiara Gandini, Ana Elisa Gonçalves, Silvia Strocchi, et al.
Acta Neuropathologica|January 6, 2018
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterationsIlaria Prada, Martina Gabrielli, Elena Turola, et al.
Journal of Medicinal Chemistry|June 30, 2022
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion ClearanceArianna Colini Baldeschi, Marco Zattoni, Silvia Vanni, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion DiseasesMatteo Staderini, Suzana Aulić, Manuela Bartolini, et al.
Molecular Neurobiology|April 13, 2022
Serpin Signatures in Prion and Alzheimer's DiseasesMarco Zattoni, Marika Mearelli, Silvia Vanni, et al.
Pageof 20